
Syneos Health SYNH
Syneos Health Langfristiger Schuldenstrom | SYNH
Langfristiger Schuldenstrom Jährlich Syneos Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 44 M | 43.1 M | 42.1 M | 38.1 M | 50.1 M | 25 M | 11.9 M | 29.8 M | 3.62 M | 4.71 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 50.1 M | 3.62 M | 29.2 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Neuronetics
STIM
|
5.56 M | $ 2.93 | 1.74 % | $ 193 M | ||
|
Thermo Fisher Scientific
TMO
|
275 M | $ 603.02 | 0.02 % | $ 227 B | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 128.06 | 2.68 % | $ 7.66 B | ||
|
Senseonics Holdings
SENS
|
496 K | $ 9.33 | 5.97 % | $ 389 M | ||
|
Sotera Health Company
SHC
|
5.76 M | $ 18.59 | 0.05 % | $ 5.28 B | ||
|
VolitionRx Limited
VNRX
|
250 K | $ 0.33 | 2.52 % | $ 41.5 M | ||
|
Waters Corporation
WAT
|
31.1 M | $ 402.91 | 0.33 % | $ 24 B | ||
|
Exagen
XGN
|
1.23 M | $ 7.3 | 0.53 % | $ 157 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
535 K | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Psychemedics Corporation
PMD
|
452 K | - | -1.84 % | $ 15.3 M | ||
|
Quotient Limited
QTNT
|
3.54 M | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 235.5 | 0.06 % | $ 26.1 B | ||
|
T2 Biosystems
TTOO
|
1.62 M | - | -39.35 % | $ 313 K | ||
|
Meridian Bioscience
VIVO
|
1.83 M | - | - | $ 1.49 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Brainsway Ltd.
BWAY
|
824 K | $ 14.16 | 0.07 % | $ 481 M | ||
|
Renalytix AI plc
RNLX
|
45 K | - | 5.66 % | $ 22.7 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Precipio
PRPO
|
410 K | $ 27.25 | 0.11 % | $ 43.7 M | ||
|
Anixa Biosciences
ANIX
|
41 K | $ 2.9 | 0.66 % | $ 94.1 K | ||
|
Biodesix
BDSX
|
1.36 M | $ 26.63 | 1.72 % | $ 201 M | ||
|
Biomerica
BMRA
|
235 K | $ 2.34 | 1.3 % | $ 6.82 M | ||
|
BioNano Genomics
BNGO
|
697 K | $ 1.2 | 1.25 % | $ 6.53 M | ||
|
Burning Rock Biotech Limited
BNR
|
16.8 M | $ 10.71 | 11.22 % | $ 113 M | ||
|
Agilent Technologies
A
|
44 M | $ 146.85 | 0.59 % | $ 41.7 B | ||
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
209 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Bioventus
BVS
|
3.3 M | $ 13.83 | 0.42 % | $ 921 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 50.31 | 2.05 % | $ 2.68 B | ||
|
Celcuity
CELC
|
54 K | $ 93.02 | 0.75 % | $ 4.35 B | ||
|
Co-Diagnostics
CODX
|
662 K | $ 1.12 | 2.55 % | $ 1.49 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 280.76 | 0.54 % | $ 13.9 B | ||
|
Castle Biosciences
CSTL
|
1.32 M | $ 32.76 | 1.03 % | $ 950 M | ||
|
Danaher Corporation
DHR
|
199 M | $ 205.23 | 0.53 % | $ 146 B | ||
|
DarioHealth Corp.
DRIO
|
430 K | $ 7.03 | 3.72 % | $ 28 M | ||
|
DexCom
DXCM
|
21.6 M | $ 84.53 | 0.02 % | $ 33 B | ||
|
Fulgent Genetics
FLGT
|
1.46 M | $ 20.2 | 2.38 % | $ 622 M |